Literature DB >> 26962739

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

F Paolo Schena1, Carlo Manno1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26962739     DOI： 10.1056/NEJMc1600141

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Adalimumab-induced IgA nephropathy.

Authors:  Aneesha Kaur Bhagat Singh; Andrew Sujeevan Jeyaruban; Gregory John Wilson; Dwarakanathan Ranganathan
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Crescent lesions are not a predictive factor in adult-onset Henoch-Schönlein purpura nephritis.

Authors:  Zheng-Xia Zhong; Jia-Xing Tan; Yi Tang; Li Tan; Gai-Qin Pei; Wei Qin
Journal:  Clin Exp Med       Date:  2019-07-10       Impact factor: 3.984

Review 3.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

4.  Multiple rare genetic variants co-segregating with familial IgA nephropathy all act within a single immune-related network.

Authors:  S N Cox; F Pesce; J S El-Sayed Moustafa; F Sallustio; G Serino; C Kkoufou; A Giampetruzzi; N Ancona; M Falchi; F P Schena
Journal:  J Intern Med       Date:  2016-10-11       Impact factor: 8.989

5.  Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial.

Authors:  Yan Li; Rongguo Fu; Jie Gao; Li Wang; Zhaoyang Duan; Lifang Tian; Heng Ge; Xiaotao Ma; Yuzhan Zhang; Ke Li; Peihao Xu; Xuefei Tian; Zhao Chen
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes.

Authors:  Wang Zhang; Ye Yuan; Xiang Li; Jiao Luo; Zhanmei Zhou; Lei Yu; Guobao Wang
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

7.  Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy.

Authors:  Tingyu Chen; Eryu Xia; Tiange Chen; Caihong Zeng; Shaoshan Liang; Feng Xu; Yong Qin; Xiang Li; Yuan Zhang; Dandan Liang; Guotong Xie; Zhihong Liu
Journal:  EBioMedicine       Date:  2020-02-12       Impact factor: 8.143

8.  Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy.

Authors:  Sharon Natasha Cox; Samantha Chiurlia; Chiara Divella; Michele Rossini; Grazia Serino; Mario Bonomini; Vittorio Sirolli; Francesca B Aiello; Gianluigi Zaza; Isabella Squarzoni; Concetta Gangemi; Maria Stangou; Aikaterini Papagianni; Mark Haas; Francesco Paolo Schena
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

Review 9.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.